| 000 | 01369 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511161847.0 | ||
| 264 | 0 | _c19770129 | |
| 008 | 197701s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoekes, A M | |
| 245 | 0 | 0 |
_aAcute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cAug 1976 |
||
| 300 |
_a789-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 |
_aCreatinine _xmetabolism |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEthanolamines _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKidney _xphysiology |
| 650 | 0 | 4 |
_aLabetalol _xadministration & dosage |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPulse _xdrug effects |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 700 | 1 | _aThompson, F D | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 3 _gno. 4 Suppl 3 _gp. 789-93 |
|
| 999 |
_c997660 _d997660 |
||